Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Clinical Therapeutics|January 21, 2020
Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further ResearchJessica Ochalek, James LomasCost Effectiveness and Resource Allocation : C/E|July 16, 2022
Supporting a review of the benefits package of the National Health Insurance Scheme in GhanaHeleen Vellekoop, Emmanuel Odame, Jessica OchalekBMJ Global Health|November 29, 2018
Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country dataJessica Ochalek, James Lomas, Karl ClaxtonApplied Health Economics and Health Policy|September 1, 2021
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology AssessmentJames Lomas, Jessica Ochalek, Rita FariaHealth Policy and Planning|August 19, 2021
Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countriesJames Lomas, Karl Claxton, Jessica OchalekJournal of Health Economics|January 21, 2020
Squaring the cube: Towards an operational model of optimal universal health coverageJessica Ochalek, Gerald Manthalu, Peter C SmithEconomics and Human Biology|September 21, 2017
Causal effects of HIV on employment status in low-income settingsJessica Ochalek, Paul Revill, Bernard van den BergExpert Review of Pharmacoeconomics & Outcomes Research|September 21, 2020
Valuing health outcomes: developing better defaults based on health opportunity costsJessica Ochalek, Karl Claxton, James Lomas, et al.Pharmacoeconomics|February 11, 2018
Cost-Effectiveness Thresholds: the Past, the Present and the FuturePraveen Thokala, Jessica Ochalek, Ashley A Leech, et al.BMJ Global Health|October 21, 2020
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countriesJessica Ochalek, Kaja Abbas, Karl Claxton, et al.Pageof 3